Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.
Xu J, Pham CG, Albanese SK, Dong Y, Oyama T, Lee CH, Rodrik-Outmezguine V, Yao Z, Han S, Chen D, Parton DL, Chodera JD, Rosen N, Cheng EH, Hsieh JJ.
Xu J, et al. Among authors: parton dl.
J Clin Invest. 2016 Sep 1;126(9):3526-40. doi: 10.1172/JCI86120. Epub 2016 Aug 2.
J Clin Invest. 2016.
PMID: 27482884
Free PMC article.